Remedy Labs, Inc. — Form D/A
Remedy Labs, Inc. of SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2015-11-17. The offering totals $1.9M, of which $1.1M was reported sold. Industry: Other Technology.
Offering
- Filed: 2015-11-17
- Form: D/A
- Accession: 0001654541-15-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.9M
- Amount sold: $1.1M
- Remaining: $800K
- Investors: 10
- Date of first sale: 2015-10-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-248722
Issuer
- Name: Remedy Labs, Inc.
- CIK: 0001654541
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 73 SUMNER STREET, APT. 303, SAN FRANCISCO, CA, 94103
- Phone: (650) 919-3446
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Victor Echevarria | Director | Pittsburgh, PA |
| Victor Echevarria | Executive Officer | Pittsburgh, PA |
| Marija Ringwelski | Executive Officer | San Francisco, CA |
| John Schulte | Executive Officer | San Francisco, CA |
Other filings by this issuer (1)
More